{"schema_version":"1","generated_at":"2026-10-28T22:51:59.175Z","data_as_of":null,"url":"https://www.findmykol.com/kol/gerald-soff","json_url":"https://www.findmykol.com/kol/gerald-soff/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"gerald-soff","name":"Gerald Soff","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Miami","institution_url":"https://www.findmykol.com/institution/university-of-miami","city":"Miami","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1871528786","orcid":"0000-0002-8781-903X","openalex":"A5076244790"},"summary":"Gerald Soff is an Oncology physician affiliated with University of Miami. OpenAlex indexes 214 publications with 9,503 citations (h-index 49); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":214,"cited_by_count":9503,"h_index":49,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05772546","title":"Avatrombopag vs. Placebo for CIT in GI Malignancies","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Hanny Al-Samkari, MD","source_url":"https://clinicaltrials.gov/study/NCT05772546","trial_url":"https://www.findmykol.com/trial/NCT05772546"},{"nct":"NCT04437953","title":"Avatrombopag for Thrombocytopenia in People With Cancer","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT04437953","trial_url":"https://www.findmykol.com/trial/NCT04437953"}],"source":"trials"},"payments":{"company_count":24,"program_years":{"first":2021,"last":null},"rows_total":41,"shown":3,"withheld":38,"rows":[{"payer":"VERTEX PHARMACEUTICALS INCORPORATED","program_year":2025,"amount_usd":9900,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871528786"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":2613.55,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871528786"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":2121.07,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871528786"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1871528786","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":17.2,"facility_pct":82.8},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A Review of Romiplostim Mechanism of Action and Clinical Applicability","year":2021,"journal":"Drug Design Development and Therapy","source_url":"https://doi.org/10.2147/dddt.s299591","status":"verified"},{"title":"The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies","year":2021,"journal":"European Journal Of Haematology","source_url":"https://doi.org/10.1111/ejh.13595","status":"verified"},{"title":"Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study","year":2021,"journal":"Annals of Neurology","source_url":"https://doi.org/10.1002/ana.26129","status":"verified"},{"title":"Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia","year":2021,"journal":"Expert Review of Hematology","source_url":"https://doi.org/10.1080/17474086.2021.1924053","status":"verified"},{"title":"Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2020007488","status":"verified"}],"source":"works"},"contact":{"address_1":"1120 NW 14TH ST STE 610","city":"Miami","state":"FL","zip":"331362107","phone":"305-243-5302","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1871528786","source":"identity"},"similar":[{"name":"Carlos Singer","slug":"carlos-singer","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/carlos-singer","json_url":"https://www.findmykol.com/kol/carlos-singer/profile.json"},{"name":"Sebastian Koch","slug":"sebastian-koch","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/sebastian-koch","json_url":"https://www.findmykol.com/kol/sebastian-koch/profile.json"},{"name":"Jay Spiegel","slug":"jay-spiegel","institution":"University of Miami","specialty":"Hematology","url":"https://www.findmykol.com/kol/jay-spiegel","json_url":"https://www.findmykol.com/kol/jay-spiegel/profile.json"},{"name":"Kara Cavuoto","slug":"kara-cavuoto","institution":"University of Miami","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/kara-cavuoto","json_url":"https://www.findmykol.com/kol/kara-cavuoto/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":38,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-07-01","provider_certified":"2021-07-01","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}